NCT04539015 is a clinical trial of Prevena Plus in Hernia, sponsored by New York Medical College.

Who is sponsoring NCT04539015?

NCT04539015 is sponsored by New York Medical College.

What drugs are being tested in NCT04539015?

Interventions in NCT04539015: Prevena Plus.

Is NCT04539015 still recruiting?

NCT04539015 is currently status unknown. Last updated 4 September 2020.

Last reviewed 2020-09-04 · How we verify

NCT04539015

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assess the Efficacy of Prevena Plus vs SOC to Closed Incision in Pts Undergoing CAWR and Other Laparotomy Procedures.

Status unknown Last updated 4 September 2020

What this trial tests

trial testing Prevena Plus in Hernia in 170 participants. Status unknown.

Timeline

9 July 2020

Primary endpoint
30 December 2022

28 February 2023

Quick facts

Lead sponsor	New York Medical College
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	170
Start date	9 July 2020
Primary completion	30 December 2022
Estimated completion	28 February 2023
Sites	1 location across United States

Drugs / interventions tested

Prevena Plus

Conditions studied

Hernia — all drugs for Hernia →

Sponsor

New York Medical College

Who can join

18 and older, any sex, with Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study to establish the efficacy of Prevena™ Plus in preventing surgical site infection after complex abdominal wall procedures and major laparotomies as compared to SOC dressing. We hypothesized that use of Prevena Plus will significantly decrease the incidence of Surgical Site Infection (SSI) and subsequently may have an impact over reducing hospital cost. Study data will be analyzed for clinical outcomes through 30 days. The patients will be followed every day during the hospital stay and study follow-up visits will be conducted in the clinic at 2 weeks and 1 month from the date of discharge.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Negative pressure wound therapy for surgical wounds healing by primary closure.
Norman G, Shi C, Goh EL, Murphy EM, et al · · 2022 · cited 71× · PMID 35471497 · DOI 10.1002/14651858.cd009261.pub7

Verify or expand the search:

Other recruiting trials for Hernia

Currently open trials in the same condition.

NCT07220382 — Preoperative BOTOX® Injection for Large Ventral Hernia Repair · Phase 4 · recruiting
NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
NCT07166172 — Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH · NA · recruiting
NCT06449378 — Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia · NA · active not recruiting
NCT06042205 — TISSIUM™ Atraumatic Hernia Repair System (TAHRS) Pilot Study · NA · active not recruiting

Other New York Medical College trials

Trials by the same sponsor.

NCT06617286 — CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma · Phase 1, PHASE2 · not yet recruiting
NCT07225972 — Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC · Phase 3 · not yet recruiting
NCT07013565 — Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL · Phase 2 · active not recruiting
NCT05987124 — Defibrotide Dose-escalation for SOS Post-HSCT · Phase 2 · recruiting
NCT05564598 — CMV CTLs in Neonates With CMV Infection · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04539015 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by New York Medical College
Last refreshed: 4 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04539015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing